Author

Ghulam Jeelani Mufti

King's College LondonORCID 0009-0004-7335-9230Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:differential expression· 2 Research Focus:gene regulatory network inference· 2 Organism:human· 2 Approach:statistical model· 2 Research Focus:cell-cell communication· 1 Research Focus:clustering· 1 Assay:DNA methylation· 1

Frequent Co-Authors

Ian Richard ThompsoniD· 2 shared Mohammad Mahdi KarimiiD· 2 shared Nogayhan SeymeniD· 2 shared Sıla GerlevikiD· 2 shared Warisha Mumtaz· 2 shared Alfredo IacoangeliiD· 1 shared Andrea PellagattiiD· 1 shared Deniz Ece KayaiD· 1 shared

Activity by Year

2024-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenomics

Ian Richard ThompsonORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

GenomicseLifePeer-reviewedOct 17, 2024

Expression of Most Retrotransposons in Human Blood Correlates with Biological Aging

Yi-Ting Tsai, Nogayhan Seymen, Ian Richard Thompson…·Mohammad Mahdi Karimi

The paper examines RTE expression and methylation in human blood, finding correlations with biological aging but not chronological age, and identifies potential mechanisms and cell types involved.

12 citations

humanbulk RNA-seq

GenomicseLifePeer-reviewedSep 5, 2024

Identification of novel myelodysplastic syndromes prognostic subgroups by integration of inflammation, cell-type composition, and immune signatures in the bone marrow

Sıla Gerlevik, Nogayhan Seymen, Shan Hama…·Mohammad Mahdi Karimi

The paper integrates inflammation, cell-type composition, and immune signatures in MDS to identify prognostic subgroups using MOFA, finding that high inflammation correlates with better prognosis while SRSF2 mutations are linked to poor outcomes.

2 citations

humanbulk RNA-seq